- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $23.69M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $25.52M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $93.8M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $104.77M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $96.1M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $96.84M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $106.96M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $114.46M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $88.03M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $100.89M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $203.25M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $221.4M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $38.65M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $44.46M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 36.58M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $88K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$13.3M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.98 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.98 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $16.25M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.23M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$35.73M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$23.47M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $37.01M |